Description
KSQ-4279 is an inhibitor of the deubiquitinating enzyme USP1.
Product Unit Size | Cost | Quantity | Stock |
---|
KSQ-4279 is an inhibitor of the deubiquitinating enzyme USP1.
Cas No. | 2446480-97-1 |
---|---|
Purity | ≥98% |
Formula | C27H25F3N8O |
Formula Wt. | 534.55 |
IUPAC Name | 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine |
Synonym | USP1-IN-1; KSQ4279 |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Cadzow L, Brenneman J, Sullivan P, et al. Development of KSQ-4279 as a first-in-class USP1 inhibitor for the treatment of BRCA-deficient cancers. Eur J Cancer. 2020 Oct 1;138(Supplement 2,S52).
Cadzow L, Tobin E, Sullivan P, et al. Abstract ND01: KSQ-4279: A first-in-class USP1 inhibitor for the treatment of cancers with homologous recombination deficiencies. Cancer Res. 2022;82(12_Supplement):ND01.
Microtubule polymerization inhibitor.
Macrolide antibiotic; peptidyl transferase inhi...
Aminoglycoside; protein translation inhibitor, ...
NSAID; COX-1/2 inhibitor.
Endogenous opioid peptide; μOR agonist.
SGLT2 inhibitor
G-quadruplex ligand; DNA breakage inducer.
Synthetic steroid hormone used in HRT; SERM, PR...
AhR antagonist.
Neuraminidase inhibitor.
O-methylated coumarin; Ca2+ channel blocker.
Hec1/Nek2 mitotic pathway inhibitor
Phenylethylamine; β2-adrenergic agonist, SK/BK...
Calcium channel blocker.
Statin; HMG-CoA reductase inhibitor.
mAChR antaonist.
GABA potentiator, voltage-gated Na+ and ATP-sen...
Peptide, involved in neutrophil activation; FPR...
Histamine H1 antagonist, FIASMA.
AurKA/B inhibitor.